Free daily briefing on global business news.
A source close to the matter told Reuters there is "no deal" and there "never was a deal to be done" between the two drugmakers
Bloomberg / Getty Images
AstraZeneca $AZN and Bristol Myers Squibb $BMY never held merger discussions and are not in talks now, a senior source close to the matter told Reuters on Wednesday.
"There is no deal between AstraZeneca and BMS. There never was a deal to be done, and there are no discussions between the companies," the source said, under the cover of anonymity. Neither company offered a comment when contacted by Reuters.
